NASDAQ:TARS

Tarsus Pharmaceuticals Stock Forecast

etoro logo Buy TARS
*Your capital is at risk
$63.16
+0.610 (+0.98%)
At Close: Jun 18, 2026
AI Analysis AI Analysis of TARS AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add TARS to Watchlist?
Some Reasons Why To Add TARS:
  • High gross margin of 90.4%
  • Low bankruptcy risk (Altman Z-Score: 7.41)
  • Lower volatility than the market (beta 0.51)
PDF

Green day on Thursday for Tarsus Pharmaceuticals, Inc.
(Updated on Jun 18, 2026)

Buy candidate since Jun 17, 2026 Gain 0.98%

The Tarsus Pharmaceuticals, Inc. stock price gained 0.98% on the last trading day (Thursday, 18th Jun 2026), rising from $62.55 to $63.16. During the last trading day the stock fluctuated 3.00% from a day low at $62.37 to a day high of $64.24. The price has been going up and down for this period, and there has been a 4.67% gain for the last 2 weeks. Volume fell on the last day by -69 thousand shares and in total, 376 thousand shares were bought and sold for approximately $23.72 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -12.43% during the next 3 months and, with a 90% probability hold a price between $48.51 and $58.57 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

TARS Signals & Forecast

Mostly positive signals in the chart today. The Tarsus Pharmaceuticals, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $62.03 and $61.81. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, June 02, 2026, and so far it has risen 10.02%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for Tarsus Pharmaceuticals, Inc. stock

Tarsus Pharmaceuticals, Inc. finds support from accumulated volume at $61.16 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.87 between high and low, or 3.00%. For the last week, the stock has had daily average volatility of 3.51%.

Our recommended stop-loss: $60.86 (-3.64%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 12 days ago.)

Trading Expectations (TARS) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Tarsus Pharmaceuticals, Inc. to open at $63.26, and during the day (based on 14 day Average True Range), to move between $61.80 and $64.52, which gives a possible trading interval of +/-$2.72 (+/-4.40%) up or down from last closing price. If Tarsus Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 4.40% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $63.96 (1.27%) than the support at $61.16 (3.17%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Tarsus Pharmaceuticals, Inc. stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.

Current score: 2.766 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 22, 2026 - $63.26 ( 0.153%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

TARS Performance

Trading levels for TARS

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 65.13 3.11%
R2 64.41 1.98%
R1 63.97 1.28%
Price 63.16
S1 62.54 -0.98%
S2 62.10 -1.68%
S3 61.39 -2.81%

Accumulated Volume Support & Resistance Levels

Level Price
R3 64.66 2.37%
R2 64.51 2.14%
R1 63.96 1.27%
Price 63.16
S1 61.16 -3.17%
S2 60.97 -3.47%
S3 59.65 -5.56%

FAQ

What is the symbol for Tarsus Pharmaceuticals, Inc. Stock and on which exchange is it traded?
The symbol for Tarsus Pharmaceuticals, Inc. is TARS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Tarsus Pharmaceuticals, Inc. Stock?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.

How to buy Tarsus Pharmaceuticals, Inc. Stock?
Tarsus Pharmaceuticals, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Tarsus Pharmaceuticals, Inc. Stock.

What's the current price of Tarsus Pharmaceuticals, Inc. Stock?
As of the end of day on the Jun 18, 2026, the price of an Tarsus Pharmaceuticals, Inc. (TARS) share was $63.16.

What is the 52-week high and low for Tarsus Pharmaceuticals, Inc. Stock?
The 52-week high for Tarsus Pharmaceuticals, Inc. Stock is $85.25 and the 52-week low is $38.52.

What is the market capitalization of Tarsus Pharmaceuticals, Inc. Stock?
As of the Jun 18, 2026, the market capitalization of Tarsus Pharmaceuticals, Inc. is 2.717B.

When is the next earnings date for Tarsus Pharmaceuticals, Inc.?
The upcoming earnings date for Tarsus Pharmaceuticals, Inc. is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT TARSUS PHARMACEUTICALS, INC.
Tarsus Pharmaceuticals
Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. The company is also developing TP-04 for the treatment of rosacea; a...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
7.76% Jun 12
DHI
$146.71
7.57% Jun 10
PHM
$118.49
7.15% Jun 10
EAT
$140.46
17.39% Jun 05
TPR
$140.47
2.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE